PHARMA SOP WORLD

Showing posts with the label stability GuidelinesShow All

stability Guidelines

Climatic Zones -Stability testing of active pharmaceutical ingredients and finished pharmaceutical products: Stability conditions for WHO Member States by Region

srikanth nagabiru November 07, 2022

The climatic condition changes as we move across the globe, which means that the climatic condition is different in a different part of the world. Th…

stability Guidelines

WHO guidelines on stability testing of pharmaceutical products containing well-established drug substances in conventional dosage forms

srikanth nagabiru November 07, 2022

Typically, both drug substance and drug product are tested in at least two different storage conditions: long term ambient storage temperature and ac…

stability Guidelines

ASEAN Guideline on Stability Study of Drug Product

srikanth nagabiru November 07, 2022

ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT Stability testing is integral to developing new pharmaceutical products and active pharmaceutical…

stability Guidelines

Guidelines for Stability Testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products(SFDA)

srikanth nagabiru November 07, 2022

Guidelines for Stability Testing of Active Pharmaceutical Ingredients and Finished Pharmaceutical Products The stability studies of pharmaceutical pr…

stability Guidelines

Q1A(R2)-ICH STABILITY GUIDELIENS

srikanth nagabiru November 07, 2022

Q1A(R2)-ICH STABILITY GUIDELIENS The following guideline is a revised version of the ICH Q1A guideline and defines the stability data package for a n…

stability Guidelines